Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : CEAPRO INC.----CZO -- Ignore unavailable to you. Want to Upgrade?

To: fivedollar who wrote (13)	6/3/1998 7:15:00 PM
From: PJ	Read Replies (1) \| Respond to of 53

Standard & Poors No.12G Reg.823486 EDMONTON, June 2 /CNW/ - Ceapro Inc. (''Ceapro'') (ASE: CZO) is pleased to announce today that shipping has now commenced under its contract with Daisen Sangyo Co. Ltd. of Japan for distribution and sale of Ceapro's Dr. Redmond's Animal Coat Wash product through Nippon Zenyaku Kogyo Co. Ltd., Japan's largest veterinarian animal health company. Nippon Zenyaku completed extensive product trials amongst some 60 veterinarians in Japan during 1997, the results of which coincided with the results of Ceapro trials in Canada. The product will be launched throughout Japan in early July supported by a major marketing program. Japan is the largest and most developed small animal market in Asia with a population of 18 million dogs and cats and Nippon Zenyaku is the dominant supplier to this market. ''As a joint-venture partner of the world's largest animal health company, Merial, Nippon Zenyaku represents a very strategic partner for Ceapro in opening this major market to our products, of which the coat wash is only the first,'' comments Douglas Clement, Ceapro's Vice President, Consumer Health Products. ''With a sales force of 300 calling directly on Japan's 6500 veterinarians, Nippon Zenyaku ensures that our products get into the mainstream animal care markets quickly and efficiently'', added Clement. Ceapro is very pleased with this partnership and sees it as an important stepping stone to opening other markets in Europe and North America later this year and in 1999. ''The initial shipment has a sales value of $375,000 CDN. Future product and sales forecasts will be provided shortly after this initial launch for this multi-million dollar potential market for Ceapro'', stated Clement. Ceapro obtains the active ingredients in its animal care product line from its wholly-owned subsidiary Canamino Inc., an advanced oat fractionation plant in Saskatoon, Saskatchewan. The ASE has neither approved nor disapproved of this release. -30- For further information: Robert A. Binnendyk, President and CEO, or Douglas M. Clement, Vice President, Consumer Health Products, Ceapro Inc., (403) 421-4555